Jan 15 (Reuters) - Becton Dickinson and Co BDX.N:
BD BOOSTS U.S. MANUFACTURING OF CRITICAL MEDICAL DEVICES
PLANS FOR MORE THAN $30 MILLION INVESTMENTS IN 2025 TO EXPAND MANUFACTURING CAPACITY FOR IV LINES AT UTAH PLANT
NEW NEEDLE, SYRINGE PRODUCTION LINES INSTALLED AT BD PLANTS IN CONNECTICUT AND NEBRASKA
Source text: ID:nPn7jRlv0a
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.